Literature DB >> 3057630

Disseminated intravascular coagulation and related syndromes: a clinical review.

R L Bick1.   

Abstract

Current concepts of the cause, pathophysiologic mechanisms, diagnosis, and management of acute and chronic DIC have been discussed. Considerable attention has been devoted to interrelationships that have remained confusing. Only by clearly understanding these pathophysiologic interrelationships can the clinician and laboratorian appreciate the divergent and wide clinical spectrum of often confusing clinical and laboratory findings in patients with DIC. Many of the therapeutic decisions to be made in these patients remain controversial and will remain so until more series of patients are published with respect to specific therapeutic modalities and survival patterns. Many syndromes that remain organ specific share common pathophysiologic properties with DIC but are identified as an independent disease entity, such as HUS, adult shock lung syndrome, eclampsia, and many other isolated organ-specific disorders. Many of these similar disorders, some systemic and some organ specific or multiorgan specific, are listed in Table 36.

Entities:  

Mesh:

Year:  1988        PMID: 3057630     DOI: 10.1055/s-2007-1002793

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  12 in total

1.  A 72-year-old woman with fever and diffuse intravascular coagulation.

Authors:  C F Allaart; G J den Ottolander; E Briët; R Bieger
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673

Review 2.  Recombinant natural anticoagulants: a review.

Authors:  P L Harper; J M Hermans; R W Carrell
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344

3.  Fatality from disseminated intravascular coagulation complicating total hip arthroplasty: a case report.

Authors:  S M Sporer; J J Callaghan
Journal:  Iowa Orthop J       Date:  1997

Review 4.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

5.  Coagulopathy in the prostate cancer patient: prevalence and clinical relevance.

Authors:  A S Adamson; J L Francis; R O Witherow; M E Snell
Journal:  Ann R Coll Surg Engl       Date:  1993-03       Impact factor: 1.891

6.  Coagulation studies in patients with orthopedic trauma.

Authors:  Kanchana Rangarajan; Arulselvi Subramanian; Jatin S Gandhi; Namit Saraf; Vijay Sharma; Kamran Farooque
Journal:  J Emerg Trauma Shock       Date:  2010-01

Review 7.  Immune thrombocytopenia in pregnancy.

Authors:  Evi Stavrou; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2009-12       Impact factor: 3.722

8.  Disseminated intravascular coagulation associated with disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome.

Authors:  G Fera; N Semeraro; V De Mitrio; O Schiraldi
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

Review 9.  Hemostatic alterations in cancer patients.

Authors:  F R Rickles; M Levine; R L Edwards
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

10.  Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis.

Authors:  F Carmassi; M Morale; F De Negri; M Carrai
Journal:  J Mol Med (Berl)       Date:  1995-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.